148 related articles for article (PubMed ID: 38095444)
1. Boosting Reactive Oxygen Species Generation with a Dual-Catalytic Nanomedicine for Enhanced Tumor Nanocatalytic Therapy.
Su G; Xu H; Zhou F; Gong X; Tan S; He Y
ACS Appl Mater Interfaces; 2023 Dec; 15(51):59175-59188. PubMed ID: 38095444
[TBL] [Abstract][Full Text] [Related]
2. Dual Size/Charge-Switchable Nanocatalytic Medicine for Deep Tumor Therapy.
Wu W; Pu Y; Shi J
Adv Sci (Weinh); 2021 May; 8(9):2002816. PubMed ID: 33977044
[TBL] [Abstract][Full Text] [Related]
3. GSH-depleting and H
Li J; Yi W; Luo Y; Yang K; He L; Xu C; Deng L; He D
Acta Biomater; 2023 Jan; 155():588-600. PubMed ID: 36328125
[TBL] [Abstract][Full Text] [Related]
4. Engineering 2D Cu-composed metal-organic framework nanosheets for augmented nanocatalytic tumor therapy.
Zhuang S; Xiang H; Chen Y; Wang L; Chen Y; Zhang J
J Nanobiotechnology; 2022 Feb; 20(1):66. PubMed ID: 35120548
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall Cu
Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
[TBL] [Abstract][Full Text] [Related]
6. Photothermal-reinforced and glutathione-triggered in Situ cascaded nanocatalytic therapy.
An P; Fan F; Gu D; Gao Z; Hossain AMS; Sun B
J Control Release; 2020 May; 321():734-743. PubMed ID: 32145265
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
8. Nanozyme-like single-atom catalyst combined with artesunate achieves photothermal-enhanced nanocatalytic therapy in the near-infrared biowindow.
Lv Q; Chi K; Shi X; Liu M; Li X; Zhou C; Shi L; Fan H; Liu H; Liu J; Zhang Y; Wang S; Wang L; Wang Z
Acta Biomater; 2023 Mar; 158():686-697. PubMed ID: 36623782
[TBL] [Abstract][Full Text] [Related]
9. MnOOH-Catalyzed Autoxidation of Glutathione for Reactive Oxygen Species Production and Nanocatalytic Tumor Innate Immunotherapy.
Zhu P; Pu Y; Wang M; Wu W; Qin H; Shi J
J Am Chem Soc; 2023 Mar; 145(10):5803-5815. PubMed ID: 36848658
[TBL] [Abstract][Full Text] [Related]
10. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
Liang R; Li Y; Huo M; Lin H; Chen Y
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
12. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO
Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R
Acta Biomater; 2024 May; ():. PubMed ID: 38801869
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Generated Reactive Oxygen Species Storm for High-Performance Ferroptosis Therapy.
Huang L; Zhu J; Xiong W; Feng J; Yang J; Lu X; Lu Y; Zhang Q; Yi P; Feng Y; Guo S; Qiu X; Xu Y; Shen Z
ACS Nano; 2023 Jun; 17(12):11492-11506. PubMed ID: 37283506
[TBL] [Abstract][Full Text] [Related]
15. Nanocatalytic theranostics with intracellular mutual promotion for ferroptosis and chemo-photothermal therapy.
Zhang M; Chen Y; Wang Q; Li C; Yuan C; Lu J; Luo Y; Liu X
J Colloid Interface Sci; 2024 Mar; 657():619-631. PubMed ID: 38071811
[TBL] [Abstract][Full Text] [Related]
16. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
[TBL] [Abstract][Full Text] [Related]
17. Bimetallic oxide nanozyme-mediated depletion of glutathione to boost oxidative stress for combined nanocatalytic therapy.
Li S; Ding H; Chang J; Dong S; Shao B; Dong Y; Gai S; He F; Yang P
J Colloid Interface Sci; 2022 Oct; 623():787-798. PubMed ID: 35636288
[TBL] [Abstract][Full Text] [Related]
18. Engineering dual catalytic nanomedicine for autophagy-augmented and ferroptosis-involved cancer nanotherapy.
Li Z; Wang C; Dai C; Hu R; Ding L; Feng W; Huang H; Wang Y; Bai J; Chen Y
Biomaterials; 2022 Aug; 287():121668. PubMed ID: 35834999
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin-Derived ROS-Generating Nanomedicine with pH-Modulated Degradability to Enhance Tumor Ferroptosis Therapy and Chemotherapy.
Xu M; Zha H; Han R; Cheng Y; Chen J; Yue L; Wang R; Zheng Y
Small; 2022 May; 18(20):e2200330. PubMed ID: 35451223
[TBL] [Abstract][Full Text] [Related]
20. Key Modulation of ROS and HSP for Effective Therapy Against Hypoxic Tumor with Multifunctional Nanosystem.
Ma B; Zhao Y; Liu X; Huo M; Wang J; Ma J; Zhang Y; Qin C
Int J Nanomedicine; 2023; 18():6829-6846. PubMed ID: 38026539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
